The global gene therapy market size was valued at USD 536.43 million in 2018 and is expected to register a CAGR of 33.9% assuming the projected successful commercialization of some of the key therapeutics, that are planned over the forecast period.
Epigenetics Diagnostic Market Size, Share, Growth, Trends and Forecast Report...Signitech
The global epigenetics diagnostic market size was valued at USD 5.5 billion in 2018 and is estimated to register a CAGR of 18.8% over the forecast period. Increasing prevalence of cancer and other chronic diseases and growing geriatric population are some of the key factors expected to drive the market.
Rising prevalence of breast cancer pertaining to factors such as prolonged exposure to endogenous oestrogens, early menarche, late age at first childbirth and late menopause will be a high impact rendering factor for the industry growth. Increasing technological advances in cancer biology and launch of several diagnostic and screening programs worldwide should drive the business size. Growing adoption of therapeutics owing to factors such as blocking estrogenic from binding to tumour cells, risk of distant reappearance, lowering jeopardy of reappearance in the breast that had tumour and reducing risk of developing disease in another breast will propel the industry growth.
Growing awareness regarding breast cancer, rising shift towards adoption of western lifestyle, short breast-feeding timeframe and rising prevalence of obesity in women after menopause will drive the industry size. Increasing rate of alcohol consumption in women, rising use of hormone replacement therapy (HRT) and oral birth control pills resulting in increased levels of oestrogen will boost the business size over the forecast period. Growing exposure to certain carcinogens and endocrine disruptors, for example in the workplace, working night shifts results in increased risk are surging up the U.S. market
Prohibitive cost associated with the use of breast cancer therapeutics may hamper the industry growth. Increasing cost of early and late-stage disease therapy, continuing care on a per-unit time basis, accounting for the major share of lifetime cost owing to relatively extended survival of breast cancer patients may further restrain the business growth
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that impacts an individual ability to focus, self-control, and perform other skills important in daily life. ADHD is caused due to biochemical, connectivity, and the structural difference in the mind. Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) mostly advances over a period and vary according to the type of causing factor and according to the age group of the person. The common symptoms in patient population are trouble at work, low self-esteem and substance abuse or ADHD, low-stress tolerance level, mood swings, and many more. Further, based on symptoms, ADHD is classified into three key categories including the predominantly inattentive, predominantly hyperactive-impulsive, and combined type. ADHD is diagnosed using a comprehensive evaluation of the patient’s mental and behavioral condition. Various treatment options are pharmacological treatment, educational interventions & other behavioral therapies, and EEG biofeedback therapies, physicians could reduce the disorder symptoms and their effects on the individual health.
The global attention deficit hyperactivity disorder (ADHD) market is expected to grow with increasing pharmaceutical R&D spending, growing healthcare expenditure, accelerating economic growth, unmet treatment needs, and mounting occurrence of ADHD. Key trends and developments of this market include progressing drugs under pipeline, high demand for dual therapy, and rising preference for EEG biofeedback therapy. However, there are some factors that can hinder the growth of the market including Medical complications of existing drug therapies, high domination of the generic pharmaceutical market, and strict government protocols
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
Biological Safety Testing Market Size, Product Analysis and Applications, 201...Signitech
The global biological safety testing market size was valued at USD 2.20 billion in 2016 and is anticipated to exhibit a CAGR of 12.2% during the forecast period.
Canada Cannabis for GI Disease Market ReportInsights10
Medical cannabinoid products are widely used in Canada to treat medical symptoms of all kinds, and gastrointestinal (GI) symptoms are among the most commonly cited reasons for use. Cannabis is also widely used recreationally, and legalization of recreational use has occurred in Canada. Cannabis can be beneficial for individuals taking opioid medications for abdominal pain. Research shows that cannabis helps patients cut down on or eliminate their need for opioids and provides treatment with fewer side effects. Cannabis also helps individuals who have difficulty eating enough by increasing appetite and can help reduce diarrhoea and nausea.
Key factors supporting the growth are rise in prevalence of cannabis intake for GI disease. The need to develop better product delivery systems and sustainable product strains. This need has, in turn, led to many companies coming up with R&D, which extensively investigates several genetic improvement strategies for cannabis. While the public opinion of cannabis has gone through many shifts, public interest in Canada has continued to grow in recent years. With the legalization of cannabis in Canada and more research, people are getting a deeper understanding of how cannabis works in humans.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
Gynecological Devices Market Size, Share and Trend Analysis ReportSignitech
The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period.
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Co...Renub Research
Renub Research (http://www.renub.com/report/personalized-medicine-diagnostics-flow-cytometry-sepsis-immunos-routine-coagulation-psychiatric-disorders-tumor-markers-molecular-blood-typing-and-other-testing-116) has announced the addition of the "Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)" report to its offering
Epigenetics Diagnostic Market Size, Share, Growth, Trends and Forecast Report...Signitech
The global epigenetics diagnostic market size was valued at USD 5.5 billion in 2018 and is estimated to register a CAGR of 18.8% over the forecast period. Increasing prevalence of cancer and other chronic diseases and growing geriatric population are some of the key factors expected to drive the market.
Rising prevalence of breast cancer pertaining to factors such as prolonged exposure to endogenous oestrogens, early menarche, late age at first childbirth and late menopause will be a high impact rendering factor for the industry growth. Increasing technological advances in cancer biology and launch of several diagnostic and screening programs worldwide should drive the business size. Growing adoption of therapeutics owing to factors such as blocking estrogenic from binding to tumour cells, risk of distant reappearance, lowering jeopardy of reappearance in the breast that had tumour and reducing risk of developing disease in another breast will propel the industry growth.
Growing awareness regarding breast cancer, rising shift towards adoption of western lifestyle, short breast-feeding timeframe and rising prevalence of obesity in women after menopause will drive the industry size. Increasing rate of alcohol consumption in women, rising use of hormone replacement therapy (HRT) and oral birth control pills resulting in increased levels of oestrogen will boost the business size over the forecast period. Growing exposure to certain carcinogens and endocrine disruptors, for example in the workplace, working night shifts results in increased risk are surging up the U.S. market
Prohibitive cost associated with the use of breast cancer therapeutics may hamper the industry growth. Increasing cost of early and late-stage disease therapy, continuing care on a per-unit time basis, accounting for the major share of lifetime cost owing to relatively extended survival of breast cancer patients may further restrain the business growth
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that impacts an individual ability to focus, self-control, and perform other skills important in daily life. ADHD is caused due to biochemical, connectivity, and the structural difference in the mind. Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) mostly advances over a period and vary according to the type of causing factor and according to the age group of the person. The common symptoms in patient population are trouble at work, low self-esteem and substance abuse or ADHD, low-stress tolerance level, mood swings, and many more. Further, based on symptoms, ADHD is classified into three key categories including the predominantly inattentive, predominantly hyperactive-impulsive, and combined type. ADHD is diagnosed using a comprehensive evaluation of the patient’s mental and behavioral condition. Various treatment options are pharmacological treatment, educational interventions & other behavioral therapies, and EEG biofeedback therapies, physicians could reduce the disorder symptoms and their effects on the individual health.
The global attention deficit hyperactivity disorder (ADHD) market is expected to grow with increasing pharmaceutical R&D spending, growing healthcare expenditure, accelerating economic growth, unmet treatment needs, and mounting occurrence of ADHD. Key trends and developments of this market include progressing drugs under pipeline, high demand for dual therapy, and rising preference for EEG biofeedback therapy. However, there are some factors that can hinder the growth of the market including Medical complications of existing drug therapies, high domination of the generic pharmaceutical market, and strict government protocols
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
Biological Safety Testing Market Size, Product Analysis and Applications, 201...Signitech
The global biological safety testing market size was valued at USD 2.20 billion in 2016 and is anticipated to exhibit a CAGR of 12.2% during the forecast period.
Canada Cannabis for GI Disease Market ReportInsights10
Medical cannabinoid products are widely used in Canada to treat medical symptoms of all kinds, and gastrointestinal (GI) symptoms are among the most commonly cited reasons for use. Cannabis is also widely used recreationally, and legalization of recreational use has occurred in Canada. Cannabis can be beneficial for individuals taking opioid medications for abdominal pain. Research shows that cannabis helps patients cut down on or eliminate their need for opioids and provides treatment with fewer side effects. Cannabis also helps individuals who have difficulty eating enough by increasing appetite and can help reduce diarrhoea and nausea.
Key factors supporting the growth are rise in prevalence of cannabis intake for GI disease. The need to develop better product delivery systems and sustainable product strains. This need has, in turn, led to many companies coming up with R&D, which extensively investigates several genetic improvement strategies for cannabis. While the public opinion of cannabis has gone through many shifts, public interest in Canada has continued to grow in recent years. With the legalization of cannabis in Canada and more research, people are getting a deeper understanding of how cannabis works in humans.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
Gynecological Devices Market Size, Share and Trend Analysis ReportSignitech
The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period.
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Co...Renub Research
Renub Research (http://www.renub.com/report/personalized-medicine-diagnostics-flow-cytometry-sepsis-immunos-routine-coagulation-psychiatric-disorders-tumor-markers-molecular-blood-typing-and-other-testing-116) has announced the addition of the "Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)" report to its offering
Global artificial intelligenceGlobal Artificial Intelligence (AI) for Drug Di...GMI Research
Global AI for Drug Discovery Market by Drug Type (Small Molecule and Large Molecules), By Technology (Deep Learning and machine learning), By Therapeutic Type (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases and Others) End-Users (Pharmaceutical Companies, Biopharmaceutical Companies, Academic and Research Institutes and Others) and by Geography – Opportunities & Forecast, 2018-2025
United States IVD Market (By Application Segments, Products, Region, End User...iGATE RESEARCH
iGATE Research has released a research report on “United States IVD Market (By Application Segments, Products, Region, End Users) Size, Share, Major Deals & Company Analysis - Forecast to 2025”
Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=166
Contact US
iGATE Research PVT LTD
Ravi Sinha
Sales Manager
Marketing and Sales Divison
Email: ravi.sinha@igateresearch.com
Contact: +91-858-684-0791, +91-821-092-7469 (INDIA)
Web: www.igateresearch.com
Molecular diagnostics market & forecast (by application, technology, countrie...Renub Research
Renub Research (http://renub.com/report/molecular-diagnostics-market-forecast-by-application-technology-countries-companies-clinical-trials-to-2017-global-analysis-114) has announced the addition of the "Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis" report to its offering
Clinical Decision Support Systems (CDSS) Industry Report, 2018 to 2024Signitech
The global clinical decision support systems (CDSS) market size was valued at USD 471.96 million in 2016. Rising demand for quality care and integrated reliable technical solutions is one of the key trends escalating market growth.
Peptide Based Cancer Therapeutics Market Size Worth $17.18 Billion By 2027 | ...OliviaThomas57
The global peptide based cancer therapeutics market size is expected to reach USD 17.18 billion by 2027 according to a new study by Polaris Market Research
Global antibody drug conjugate market & pipeline insight2020KuicK Research
" Global Antibody Drug Conjugate Market & Pipeline Insight 2020" Report Highlight:
Global Antibody Drug Conjugates Market Overview
Mechanism of Antibody Drug Conjugates
Global Antibody Drug Conjugates Clinical Pipeline by Company, Indication & Phase
Global Antibody Drug Conjugates Clinical Pipeline: 148 ADC
Marketed Antibody Drug Conjugates Clinical Insight: 8 ADC
Antibody Drug Conjugates Patent Analysis
Global Antibody Drug Conjugates Market Future Prospects
AlphaImpactRx Barclays Oncology Webinar 1 Dec 2015Lesley Bailey
AlphaImpactRx and Barclays Capital conducted a webinar on the emerging dynamics of today’s US oncology market on Tuesday, December 1st from 12-1 pm EST.
Mark Purcell, head of Barclays global pharmaceutical equity research team and Stacy Mecham, SVP, Oncology Franchise at AlphaImpactRx presented the latest data in immuno-oncology, including late-breaking news on PD-L1 testing, as well as developing trends in breast cancer and CLL treatment to get you ready for the upcoming ASH and San Antonio Breast Cancer conferences.
Competition across the immuno-oncology battlefield is heating up behind the recent launches of Opdivo and Keytruda, and it promises to get more crowded in the near future. We’ll provide unique insight generated from the AlphaImpactRx point-of-care data to help you understand who’s gaining traction, and where it’s being gained, in both NSCLC and melanoma. We’ll provide a first look into the prevalence and influence of PD-LI testing in its early days, as well as a view of the latest treatment strategies emerging in the competitive breast cancer and CLL markets.
According to www.techsciresearch.com latest Report- Global oncology drugs market is projected to grow at a brisk rate over the forecast period owing to widespread prevalence of cancer, globally.
Report URL- https://www.techsciresearch.com/report/oncology-drugs-market/4689.html
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
Cancer Diagnostics Global Market estimated to be worth $10,627.4 million by 2026Vinay Shiva Prasad
Increasing prevalence of different types of cancers, increasing awareness of personalized medicine, national program for cancer control by individual countries, availability of companion diagnostics, growth in the point of care testing, increase in sequencing-based tests and other molecular and immunology based techniques are driving the growth of cancer diagnostics.
Cancer immunotherapies from the perspectives of oncology nursesZeena Nackerdien
This presentation, tailored for oncology nurses, provides an overview of immunotherapy classes, how they work, and how key side effects are typically managed. (Disclaimer: Content is based on peer-reviewed literature; however, it is not a substitute for medical advice. Please consult your doctor)
Growth in Leading Regional and National Markets – North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico
Viral Vector and Plasmid DNA Manufacturing Market Insights, 2019 to 2025Signitech
The global viral vector and plasmid DNA manufacturing market size was valued at USD 270.2 million in 2017.It is anticipated to witness a CAGR of about 16.0% during the forecast period.
Global artificial intelligenceGlobal Artificial Intelligence (AI) for Drug Di...GMI Research
Global AI for Drug Discovery Market by Drug Type (Small Molecule and Large Molecules), By Technology (Deep Learning and machine learning), By Therapeutic Type (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases and Others) End-Users (Pharmaceutical Companies, Biopharmaceutical Companies, Academic and Research Institutes and Others) and by Geography – Opportunities & Forecast, 2018-2025
United States IVD Market (By Application Segments, Products, Region, End User...iGATE RESEARCH
iGATE Research has released a research report on “United States IVD Market (By Application Segments, Products, Region, End Users) Size, Share, Major Deals & Company Analysis - Forecast to 2025”
Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=166
Contact US
iGATE Research PVT LTD
Ravi Sinha
Sales Manager
Marketing and Sales Divison
Email: ravi.sinha@igateresearch.com
Contact: +91-858-684-0791, +91-821-092-7469 (INDIA)
Web: www.igateresearch.com
Molecular diagnostics market & forecast (by application, technology, countrie...Renub Research
Renub Research (http://renub.com/report/molecular-diagnostics-market-forecast-by-application-technology-countries-companies-clinical-trials-to-2017-global-analysis-114) has announced the addition of the "Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis" report to its offering
Clinical Decision Support Systems (CDSS) Industry Report, 2018 to 2024Signitech
The global clinical decision support systems (CDSS) market size was valued at USD 471.96 million in 2016. Rising demand for quality care and integrated reliable technical solutions is one of the key trends escalating market growth.
Peptide Based Cancer Therapeutics Market Size Worth $17.18 Billion By 2027 | ...OliviaThomas57
The global peptide based cancer therapeutics market size is expected to reach USD 17.18 billion by 2027 according to a new study by Polaris Market Research
Global antibody drug conjugate market & pipeline insight2020KuicK Research
" Global Antibody Drug Conjugate Market & Pipeline Insight 2020" Report Highlight:
Global Antibody Drug Conjugates Market Overview
Mechanism of Antibody Drug Conjugates
Global Antibody Drug Conjugates Clinical Pipeline by Company, Indication & Phase
Global Antibody Drug Conjugates Clinical Pipeline: 148 ADC
Marketed Antibody Drug Conjugates Clinical Insight: 8 ADC
Antibody Drug Conjugates Patent Analysis
Global Antibody Drug Conjugates Market Future Prospects
AlphaImpactRx Barclays Oncology Webinar 1 Dec 2015Lesley Bailey
AlphaImpactRx and Barclays Capital conducted a webinar on the emerging dynamics of today’s US oncology market on Tuesday, December 1st from 12-1 pm EST.
Mark Purcell, head of Barclays global pharmaceutical equity research team and Stacy Mecham, SVP, Oncology Franchise at AlphaImpactRx presented the latest data in immuno-oncology, including late-breaking news on PD-L1 testing, as well as developing trends in breast cancer and CLL treatment to get you ready for the upcoming ASH and San Antonio Breast Cancer conferences.
Competition across the immuno-oncology battlefield is heating up behind the recent launches of Opdivo and Keytruda, and it promises to get more crowded in the near future. We’ll provide unique insight generated from the AlphaImpactRx point-of-care data to help you understand who’s gaining traction, and where it’s being gained, in both NSCLC and melanoma. We’ll provide a first look into the prevalence and influence of PD-LI testing in its early days, as well as a view of the latest treatment strategies emerging in the competitive breast cancer and CLL markets.
According to www.techsciresearch.com latest Report- Global oncology drugs market is projected to grow at a brisk rate over the forecast period owing to widespread prevalence of cancer, globally.
Report URL- https://www.techsciresearch.com/report/oncology-drugs-market/4689.html
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
Lantern Pharma is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic date to streamline the drug development process and to identify patients who will benefit from their targeted oncology therapies. Their portfolio of therapies consists of compounds that others have tried, but failed, to develop into an approved commercialized drug. Additionally, they develop new compounds with the assistance of their A.I. platform (RADR) and biomarker driven approach. The Company is currently developing four therapeutic programs.
Cancer Diagnostics Global Market estimated to be worth $10,627.4 million by 2026Vinay Shiva Prasad
Increasing prevalence of different types of cancers, increasing awareness of personalized medicine, national program for cancer control by individual countries, availability of companion diagnostics, growth in the point of care testing, increase in sequencing-based tests and other molecular and immunology based techniques are driving the growth of cancer diagnostics.
Cancer immunotherapies from the perspectives of oncology nursesZeena Nackerdien
This presentation, tailored for oncology nurses, provides an overview of immunotherapy classes, how they work, and how key side effects are typically managed. (Disclaimer: Content is based on peer-reviewed literature; however, it is not a substitute for medical advice. Please consult your doctor)
Growth in Leading Regional and National Markets – North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico
Viral Vector and Plasmid DNA Manufacturing Market Insights, 2019 to 2025Signitech
The global viral vector and plasmid DNA manufacturing market size was valued at USD 270.2 million in 2017.It is anticipated to witness a CAGR of about 16.0% during the forecast period.
Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By Service (In-house, Outsourced), By End-use And Segment Forecasts, 2018 - 2025
Personalized Medicine Market is Projected to Reach $2,452.5 Billion by 2022Grand View Research
Personalized Medicine (PM) Market Analysis By Product (PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness) And Segment Forecasts To 2022
Cell Line Development Market Size, Share & Trends Analysis Report by Product, By Source (Mammalian, Non-Mammalian), By Type of Cells, By Application, By Technology, And Segment Forecasts, 2012 - 2022
Biochip Market - Overview and Growth ReportSignitech
Global biochip market was valued at USD 7.63 billion in 2015. Presence of strong demand for proteomics - and genomics research-oriented products along with a comprehensive drug development pipeline is expected to drive growth in revenue.
Multiple myeloma therapeutics in major developed markets to 2021 growth dri...David2591
Most up-to-date research on "Multiple Myeloma Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Revlimid and Emerging Supplementary Treatments" to its huge collection of research reports.
Download Global antibody drug conjugate market & pipeline insight2020KuicK Research
\" Global Antibody Drug Conjugate Market & Pipeline Insight 2020\" Report Highlight:
Global Antibody Drug Conjugates Market Overview
Mechanism of Antibody Drug Conjugates
Global Antibody Drug Conjugates Clinical Pipeline by Company, Indication & Phase
Global Antibody Drug Conjugates Clinical Pipeline: 148 ADC
Marketed Antibody Drug Conjugates Clinical Insight: 8 ADC
Antibody Drug Conjugates Patent Analysis
Global Antibody Drug Conjugates Market Future Prospects
Global Biotechnology Market is estimated to reach $726.8 billion by 2025; growing at a CAGR of 8.1% from 2017 to 2025. Biotechnology is the technology to upgrade or modify the whole part of biological system for human and industrial welfare. It is defined as the industrial application of living organisms and their biological processes such as microbiology, genetic engineering, biochemistry among others, so as to make best usage of the microorganisms for the benefit of mankind. Industrial biotechnology application has also steered some clear processes that produces less waste, less energy and water. It is also used in various industrial sectors such as pulp chemical, paper, textiles, minerals and metal industries, among others.
Scaffold Technology Market Size & Forecast, By Product (Hydrogels, Micro-Patterned Surface Microplates, Polymeric & Nanofiber Scaffold), By Application, By End-Use And Trend Analysis From 2018 To 2024
U.S. Specialty Injectable Generics Market Size, Share and Research Report, 20...Signitech
The U.S. specialty injectable generics market size was valued at USD 8.05 billion in 2016 and is expected to witness a lucrative CAGR of 14.9% over the forecast period. Increase in prevalence of target diseases, such as cancer, hepatitis C, multiple sclerosis, and others, has resulted in high demand for specialty generic drugs.
The Biologics Market was worth USD 267.58 billion in 2014 and is expected to reach approximately USD 373.66 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 3.78% during the forecast period. Biologics are medicates as hereditarily built proteins, got from human qualities. According to the US FDA, biologics can be made out of sugars, proteins, or nucleic acids or complex blends of these substances, or might live elements, for example, cells and tissues. The biologic medications are taken from an assortment of regular sources, for example, people, creatures, or microorganisms and comprise of items, for example, antibodies, blood and blood parts, allergenic, substantial cells, quality treatment, tissues, and recombinant remedial proteins. Propelled biotechnology strategies and complex procedures are utilized to produce biologics. They are at the cutting edge of biomedical research.
Owing to the growing applications of bioinformatics in drug discovery and development process, rising number of personalized medicines and clinical diagnostics also promotes use of bioinformatics. Moreover, growing information technology applications in bioinformatics and bioinformatics support in development of biomarker for safer drugs are some major drivers of the global bioinformatics market.
Global gene therapy market & pipeline insightKuicK Research
“Global Gene Therapy Market & Pipeline Insight” Market Highlight:
Gene Therapy Market Overview
Significance of Gene Therapy in Cancer Therapeutics
Current Applications of Gene Therapy to Cancer Treatment
Gene Therapy Market Dynamics: Drivers, Challenges & Future Outlook
FDA & AMA Guidelines for Gene Therapy
Gene Therapy Pipeline by Phase, Indications, Country & Company
Gene Therapy Pipeline: 246 Drugs
Marketed Gene Therapy: 2 (Gendicine & Rexin-G)
Cancer Gene Therapy Pipeline: 69 Drugs
Stem cell media market global trends, market share, industry size, growth, op...itejasmore
Stem cell media market global trends, market share, industry size, growth, opportunities, and market forecast. FutureWise Market Research and Reports - US and UK
Minimal Residual Disease Market 2023: Epidemiology, Industry Trends, Size, Sh...frankmorgan27
The rising instances of hematologic malignancies and the inflating need to treat these conditions using radiotherapy and chemotherapy are primarily driving the minimal residual disease market.
Stem Cell Manufacturing Market PPT: Overview, Dynamics, Trends, Segmentation,...IMARC Group
The global stem cell manufacturing market size reached US$ 13.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.1% during 2024-2032.
More Info:- https://www.imarcgroup.com/stem-cell-manufacturing-market
Similar to Gene Therapy Market Size, Share, Growth Analysis and Forecast Report, 2019 to 2026 (20)
For the time being, we are offering the International Foundation Programme (IFP) and the BSc Hons Business Studies.
We are looking to offer more variety of courses in the near future.
All the programmes offered at Ulster University, Qatar are approved and licensed by the Ministry of Education and Higher Education in Qatar.
Doha British School Ain Khaled Year Book 2019-2020Signitech
This yearbook shows that 2019/20 has been filled with a myriad of creative, sporting and cultural events. All these would have not been possible without our great facilities, wonderful teachers and support staff and most importantly our fantastic and tremendously talented students. We are trying to build the tradition of excellence and now it became our habit.
City University College is a modern and dynamic higher education institution that creates opportunity for all. It originally offered the vocational pathway of studying through its BTEC degrees awarded by Pearson Education in the UK, then partnered with Ulster University to offer a parallel academic pathway through which BTEC students can top their Higher National Diploma with a Bachelor Honours degree and a post-graduate degree. For more info. download our prospectus
U.S. Frozen Food Market Size, Share, Growth, Trends and Industry Research Rep...Signitech
The U.S. frozen food market size was USD 51.97 billion in 2015. There has been a steady rise in income in the U.S. thus causing a change in lifestyle. This change in lifestyle is facilitating the U.S. frozen food market growth.
Global adhesion promoter market was valued USD 2.56 billion in 2015. Rising demand for better adhesion in the composites & plastics sector is projected to boost the market demand over the forecast period.
Complementary and Alternative Medicine Industry Growth and Statistics, 2019 t...Signitech
The global complementary and alternative medicine market size was valued at USD 59.76 billion in 2018 and is anticipated to expand at a CAGR of 17.07% during the forecast period. Increasing awareness regarding traditional therapy methods is projected to drive the growth.
Computerized Physician Order Entry (CPOE) Market Research Report, 2024Signitech
The global computerized physician/provider order entry (CPOE) market was valued at USD 1.1 billion in 2015 and is expected to grow at a CAGR of 6.2% over the forecast period. The growing incidence of medication errors at the ordering or transcribing stage is one of significant drivers influencing the growth of CPOE market.
Nonmydriatic Handheld Fundus Camera Market Size and Share, 2018 to 2025Signitech
The global nonmydriatic handheld fundus camera market size was valued at USD 93.2 million in 2017 and is anticipated to expand at a CAGR of 9.1% over the forecast period.
Latin America Ostomy Care Bags Market Research Report, 2018 to 2025Signitech
The Latin America ostomy care bags market size was valued at USD 226.53 million in 2017 and is anticipated to register a CAGR of 6.6% over the forecast period.
Global Veterinary Reference Laboratory (VRL) Market Research, 2018 to 2025Signitech
The global veterinary reference laboratory (VRL) market size was valued at USD 2.350 billion in 2016 and is expected to grow with CAGR of 9.1% during the forecast period.
Medical Marijuana Market Size, Share, Trends and Growth Analysis Research, 20...Signitech
The global medical marijuana market size was valued at USD 11.4 billion in 2015 and is projected to grow with CAGR of 17.1% during the forecast period.
Practice Management System Market Share and Size, 2018 to 2024Signitech
The global practice management system market size was valued at USD 6.9 billion in 2015. The industry is majorly driven by its competence to bring efficiency in healthcare delivery.
Radiology Information System Market Growth and Trends, 2018 to 2024Signitech
The global radiology information system market size was valued at over USD 528.4 million in 2015. RIS is an advanced technology that enables physicians and radiologists to keep a complete record of patient history and radiology imaging data in an electronic form.
Business Process Management Software (BPM) Market Statistics, 2016 to 2024Signitech
The business process management (BPM) software market is anticipated to witness significant growth on account of growing demand for business process automation.
Molecular Diagnostics Industry Analysis Report, 2016 To 2024Signitech
Projected to grow at a CAGR of almost 9% from 2016 to 2024, the molecular diagnostics market is expected to witness significant growth over the forecast period owing to rapid surge of infectious diseases.
Under Pressure : Kenneth Kruk's StrategyKenneth Kruk
Kenneth Kruk's story of transforming challenges into opportunities by leading successful medical record transitions and bridging scientific knowledge gaps during COVID-19.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Letter to MREC - application to conduct studyAzreen Aj
Application to conduct study on research title 'Awareness and knowledge of oral cancer and precancer among dental outpatient in Klinik Pergigian Merlimau, Melaka'
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...The Lifesciences Magazine
Cold Sores, medically known as herpes labialis, are caused by the herpes simplex virus (HSV). HSV-1 is primarily responsible for cold sores, although HSV-2 can also contribute in some cases.
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Gene Therapy Market Size, Share, Growth Analysis and Forecast Report, 2019 to 2026
1. Follow Us:
Gene Therapy Market Size, Share, Growth, Trends, Regional
Outlook and Forecast, 2019 to 2026
The global gene therapy market size is expected to reach USD 5.55 billion by 2026, growing at a CAGR of 33.9% over
the forecast period, according to a new report by Grand View Research, Inc. Gene therapy is being developed with
an aim to identify and cure rare conditions, diseases that have limited treatment options and that need lifelong
medication to keep the symptoms in check. For instance, metabolic disorders like lysosomal diseases need constant
medical attention with the medication available now, however, gene therapy might become a one-time cure to such
diseases.
There are a number of molecules under development due to intense competition. This factor is projected to be the
key factor propelling the market growth. In early 2018, there were more than 950 molecules in the pipeline with
various regulatory bodies in various clinical phases. However, around 76% of the molecules are in the developmental
or preclinical stages and are expected to be available by the late 2020s. Larger pharma/biotech companies are
entering into the market by either acquiring the licensing/manufacturing rights from smaller companies that are
solely dedicated to gene therapy research or by building a dedicated research portfolio with investments and clinical
trials.
These factors are also expected to boost the market growth over the next two decades. Most of the manufacturers
are also developing molecules that can help cure various cancers. Growing prevalence of different types of cancer
emphasizes the need for the development of robust treatment options. Ongoing developments in cancer gene
“Global gene therapy market size was valued at USD 536.43 million in 2018 and is
expected to register a CAGR of 33.9% by 2026”
2. Follow Us:
studies have provided significant information about cancer-related molecular signatures, which in turn, is expected
to support the ongoing clinical trials for cancer therapeutics.
Further key findings from the study suggest:
7 gene therapy molecules have been approved by various regulatory bodies. In 2018, the FDA approved 3
molecules
Lentivirus is being used as viral vector of choice for 2 of the 3 molecules approved by the FDA
U.S. and Europe are expected to occupy the largest market shares over the forecast period owing to gene
therapy molecules being marketed in these regions
Europe is set to grow at a fast pace due to the growing pipeline molecules and a number of companies
competing in the regional market
Key companies in the market are Novartis AG, Gilead Sciences, Inc.; UniQure N.V.; Spark Therapeutics LLC;
Bluebird Bio; Juno Therapeutics; GlaxoSmithKline PLC; Celgene Corporation; Shire PLC; Sangamo Biosciences,
Inc.; Dimension Therapeutics, Inc.; Voyager Therapeutics, Inc.; Human Stem Cell Institute; Chiesi Farmaceutici
S.p.A.; and Bristol-Myers Squibb Company
Grand View Research has segmented the global gene therapy market on the basis of indication, vector, and region:
Gene Therapy Indication Outlook (Revenue, USD Million, 2014 - 2026)
Acute Lymphoblastic Leukemia (ALL)
Inherited Retinal Disease
Large B-Cell Lymphoma
ADA-SCID
Melanoma (Lesions)
Beta-Thalassemia Major/SCD
Head & Neck Squamous Cell Carcinoma
Peripheral Arterial Disease
Gene Therapy Vector Outlook (Revenue, USD Million, 2014 - 2026)
Lentivirus
Adeno-Associated Virus (AAV)
3. Follow Us:
RetroVirus & Gamma RetroVirus
Modified Herpes Simplex Virus
Adenovirus
Vaccinia Virus
Baculovirus (Bacmid)
NON-VIRAL Plasmid Vector
Injection of Naked DNA
Lipofection
Gene Therapy Regional Outlook (Revenue, USD Million, 2014 - 2026)
North America
o U.S.
Europe
Asia Pacific
Rest of the World
Access full research report on global gene therapy market:
https://www.grandviewresearch.com/industry-analysis/gene-therapy-market
4. Follow Us:
Table of Content of Global Gene Therapy Market Research Report:
Chapter 1. Research Methodology
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2. Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3. Gene Therapy Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Product Pipeline Analysis, by Stage
3.4 Industry Analysis
3.4.1 Cost structure analysis
3.4.2 User perspective analysis
3.4.2.1 Consumer behavior analysis
3.4.2.2 Market influencer analysis
3.4.3 Procedure cost analysis
3.5 Technology Overview
3.5.1 Technology timeline
5. Follow Us:
3.6 Regulatory Framework
3.6.1 Reimbursement framework
3.6.2 Standards & compliance
3.6.3 Safety
3.7 Market Dynamics
3.7.1 Market driver analysis
3.7.1.1 Robust pipeline in development
3.7.1.2 Introduction of technological advancements
3.7.1.3 Increasing investment from the companies and partnerships
3.7.1.4 Growing prevalence of target diseases and increased demand for innovative medicine
3.7.2 Market restrain analysis
3.7.2.1 Presence of ambiguous regulatory framework
3.7.2.2 High prices of gene therapy medicines
3.7.3 Industry challenges
3.7.3.1 High cost of development
3.7.3.2 Vector availability
3.8 Gene Therapy Market Analysis Tools
3.8.1 Industry Analysis - Porter's
3.8.1.1 Supplier power - High
3.8.1.2 Buyer power - Medium
3.8.1.3 Substitution threat - High
3.8.1.4 New entrants threat - Medium
3.8.2 PESTEL analysis
3.8.2.1 Political Landscape
3.8.2.2 Environmental Landscape
3.8.2.3 Social Landscape
3.8.2.4 Technology Landscape
3.8.2.5 Legal Landscape
3.8.3 Major Deals & Strategic Alliances Analysis
3.8.3.1. Joint Ventures
3.8.3.2. Mergers & Acquisitions
6. Follow Us:
3.8.3.3. Licensing & Partnership
3.8.3.4. Technology Collaborations
3.8.3.5. Strategic Divestments
3.8.4 Market entry strategies
3.8.5 Case studies
Chapter 4. Gene Therapy Market - Competitive Analysis
4.1. Recent developments & impact analysis, by key market participants
4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.3. Vendor Landscape
4.3.1. List of key distributors and channel partners
4.3.2. Key customers
4.3.3. Key company market share analysis, 2018
4.4. Public Companies
4.4.1. Company market position analysis
4.4.2. Company Market Share/Ranking, by region
4.4.3. Competitive Dashboard Analysis
4.4.3.1. Market Differentiators
4.4.3.2. Synergy Analysis: Major Deals & Strategic Alliances
4.5. Private Companies
4.5.1. List of key emerging companies’ /technology disruptors/innovators
4.5.2. Funding Outlook (Optional)
4.5.3. Regional network map
4.5.4. Company market position analysis (geographic presence, product portfolio, key alliance,
industry experience)
4.5.5. Supplier Ranking
Chapter 5. Gene Therapy Market Outlook, Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Indication Market Share Analysis, 2018 to 2026
5.3 Segment Dashboard
5.4 Gene Therapy Market, by Indication, 2014 to 2026
5.5 Market Size & Forecasts and Trend Analysis, 2014 to 2026
7. Follow Us:
5.5.1 Acute Lymphoblastic Leukemia (ALL)
5.5.2 Inherited Retinal Disease
5.5.3 Large B-cell Lymphoma
5.5.4 ADA-SCID
5.5.5 Melanoma (lesions)
5.5.6 Beta-thalassemia Major/SCD
5.5.7 Head & Neck Squamous Cell Carcinoma
5.5.8 Peripheral Arterial Disease
5.6 Gene Therapy Market Share by Vector, 2014 to 2026
5.7 Market Size & Forecasts and Trend Analysis, 2014 to 2026
5.7.1 Lentivirus
5.7.2 Adeno-associated Virus
5.7.3 Retrovirus & Gamma Retrovirus
5.7.4 Modified Herpes Simplex Virus
5.7.5 Adenovirus
5.7.6 Vaccinia Virus
5.7.7 Baculovirus (Bacmid)
5.7.8 Non-viral Plasmid Vector
5.7.9 Injection of naked DNA
5.7.10 Lipofection
Chapter 6. Gene Therapy Market: Regional Estimates & Trend analysis, by Indication & Vector Type
6.1 Regional Market Snapshot
6.2 Regional Market Share and Leading Players, 2018
6.2.1 North America
6.2.2 Europe
6.2.3 Asia Pacific
6.2.4 Rest of World
6.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
8. Follow Us:
6.3.4. Rest of World
6.4 Market Size, & Forecasts, and Trend Analysis, 2018 to 2026:
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Rest of World
Chapter 7. Company Profiles
7.1 Company Profiles
7.1.1 UniQure N.V
7.1.1.1 Company overview
7.1.1.2 Financial performance
7.1.1.3 Product benchmarking
7.1.1.4 Strategic initiatives
7.1.2 Spark Therapeutics LLC
7.1.2.1 Company overview
7.1.2.2 Financial performance
7.1.2.3 Product benchmarking
7.1.2.4 Strategic initiatives
7.1.3 Bluebird Bio
7.1.3.1 Company overview
7.1.3.2 Financial performance
7.1.3.3 Product benchmarking
7.1.3.4 Strategic initiatives
7.1.4 Celgene Corporation
7.1.4.1 Company overview
7.1.4.2 Financial Performance
7.1.4.3 Product benchmarking
7.1.4.4 Strategic initiatives
7.1.5 GlaxoSmithKline plc.
7.1.5.1 Company overview
7.1.5.2 Financial performance
14. Follow Us:
7.1.38.2 Financial performance
7.1.38.3 Product benchmarking
7.1.38.4 Strategic initiatives
7.2 List of Companies
15. Follow Us:
About Grand View Research, Inc.:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed business decisions, the company offers
market intelligence studies ensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: http://www.grandviewresearch.com